Principal Medical Bypass Graft

The Principal Medical Bypass Graft is a cutting-edge solution designed to improve outcomes in lower extremity bypass procedures. Constructed from expanded polytetrafluoroethylene (ePTFE), this vascular graft features a proximal venous anastomosis, offering a unique approach to addressing the challenges of limited runoff and intimal hyperplasia.

The Principal Medical Bypass Graft is meticulously engineered to provide an additional route for runoff, which is crucial for the successful management of peripheral arterial disease. The graft’s ePTFE material is renowned for its biocompatibility and durability, ensuring a reliable and long-lasting solution for patients requiring lower extremity bypass surgery.

By addressing the primary issues of limited runoff and intimal hyperplasia, the Principal Medical Bypass Graft aims to enhance the long-term patency rates of lower extremity bypass procedures. Its innovative design has the potential to significantly reduce the risk of graft occlusion, thereby improving clinical outcomes for patients.

The Principal Medical Bypass Graft incorporates advanced features such as a proximal venous anastomosis, which facilitates optimal blood flow and reduces the likelihood of complications. The graft’s ePTFE structure is specifically designed to minimize the occurrence of intimal hyperplasia, a common cause of graft failure. With a focus on improving patency rates and patient quality of life, the graft represents a significant advancement in vascular surgery.

1. Haimovici’s Vascular Surgery – fifth edition. Chapter 47: Extended Techniques for Limb Salvage Using Complementary Fistulas Combined with Deep Vein Interposition. Pg. 596. Enrico Ascher
2. Fichelle JM, Marzelle J, Colacchio G, Gigou F, Cormier F, Cormier JM. Infrapopliteal polytetrafluoroethylene and composite bypass: factors influencing patency. Ann Vasc Surg 1995;9:187-96.
3. Schouten O, Hoedt MTC, Wittens CHA, Hop WCJ, van Sambeek MR, van Urk H, et al. End-to-end versus end-to-side distal anastomosis in femoropopliteal bypasses; results of a randomised multicenter trial. Eur J Vasc Endovasc Surg 2005;29:457-62.
4. J Vasc Surg. 2004 Nov;40(5):924-31. Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial.
5. Diabetic Foot Lower Arterial Disease and Limb Salvage Chapter 23 Distal Arteriovenous Fistulas in prosthetic Distal Bypasses pg. 245 Herbert Dardik and Theresa M. Impeduglia